Bifunctional Bismuth‐Based Layered Double Hydroxide Sonosensitizer for Magnetic Resonance Imaging‐Guided Sonodynamic Cancer Therapy
Small · 2024
DOI: 10.1002/smll.202404475 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, 2024. Verfasst von Min Cao und 8 weiteren Autor:innen. Beteiligte Einrichtung: The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People's Hospital, Quzhou, Zhejiang, 324000, P. R. China. Hauptthemen laut MEDLINE: Bismuth, Magnetic Resonance Imaging, Hydroxides. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Wenzhou Basic Public Welfare Research Project, Competitive Research Project of Quzhou Science &Technology Bureau.
Abstract (Originalsprache)
Novel inorganic sonosensitizers with excellent reactive oxygen species (ROS) generation activity and multifunctionality are appealing in sonodynamic therapy (SDT). Herein, amorphous bismuth (Bi)‐doped CoFe‐layered double hydroxide (a‐CoBiFe‐LDH) nanosheets are proposed via crystalline‐to‐amorphous phase transformation strategy as a new type of bifunctional sonosensitizer, which allows ultrasound (US) to trigger ROS generation for magnetic resonance imaging (MRI)‐guided SDT. Importantly, a‐CoBiFe‐LDH nanosheets exhibit much higher ROS generation activity (≈6.9 times) than that of traditional TiO 2 sonosensitizer under US irradiation, which can be attributed to the acid etching‐induced narrow band gap, high electron (e − )/hole (h + ) separation efficiency and inhibited e − /h + recombination. In addition, the paramagnetic properties of Fe ion endow a‐CoBiFe‐LDH with excellent MRI contrast ability, making it a promising contrast agent for T 2 ‐weighted MRI. After modification with polyethylene glycol, a‐CoBiFe‐LDH nanosheets can function as a high‐efficiency sonosensitizer to activate p53, MAPK, oxidative phosphorylation, and apoptosis‐related signaling pathways, ultimately inducing cell apoptosis in vitro and tumor ablation in vivo under US irradiation, which shows great potential for clinical cancer treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People's Hospital, Quzhou, Zhejiang, 324000, P. R. China.
- State Key Laboratory of Chemical Resource Engineering, Beijing Advanced Innovation Center for Soft Matter Science and Engineering, Beijing University of Chemical Technology, Beijing, 100029, P. R. China.
- College of Pharmacy, Wenzhou Medical University, Wenzhou, 325000, P. R. China.
- Quzhou Institute for Innovation in Resource Chemical Engineering, Quzhou, 324000, P. R. China.
ORCID-Profile: Ruizheng Liang
Förderung
- National Natural Science Foundation of China
- Wenzhou Basic Public Welfare Research Project
- Competitive Research Project of Quzhou Science &Technology Bureau
- Fundamental Research Funds for the Central Universities of Beijing University of Chemical Technology
- Excellent Young Scientists Fund
Zitieren
APA
Cao, M., Yang, S., Li, J., Yang, Y., Zhan, L., Wang, T., Hu, T., Liang, R., & Li, Z. (2024). Bifunctional Bismuth‐Based Layered Double Hydroxide Sonosensitizer for Magnetic Resonance Imaging‐Guided Sonodynamic Cancer Therapy. Small. https://doi.org/10.1002/smll.202404475
Vancouver
Cao M, Yang S, Li J, Yang Y, Zhan L, Wang T, et al. Bifunctional Bismuth‐Based Layered Double Hydroxide Sonosensitizer for Magnetic Resonance Imaging‐Guided Sonodynamic Cancer Therapy. Small. 2024. doi:10.1002/smll.202404475
BibTeX
@article{Cao2024,
author = {Cao, Min and Yang, Shuqing and Li, Jie and Yang, Yu and Zhan, Linsen and Wang, Tao and Hu, Tingting and Liang, Ruizheng and Li, Zhangping},
title = {Bifunctional Bismuth‐Based Layered Double Hydroxide Sonosensitizer for Magnetic Resonance Imaging‐Guided Sonodynamic Cancer Therapy},
journal = {Small},
year = {2024},
doi = {10.1002/smll.202404475}
}
EUVIMED